UNICA IRIS Institutional Research Information System

PINNA, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 59.468
NA - Nord America 2.953
AS - Asia 1.299
Continente sconosciuto - Info sul continente non disponibili 193
SA - Sud America 189
AF - Africa 29
OC - Oceania 2
Totale 64.133
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 58.771
US - Stati Uniti d'America 2.898
SG - Singapore 515
CN - Cina 427
UA - Ucraina 177
BR - Brasile 148
VN - Vietnam 142
SE - Svezia 140
DE - Germania 102
GB - Regno Unito 78
FI - Finlandia 68
FR - Francia 53
HK - Hong Kong 52
IN - India 29
BD - Bangladesh 21
CA - Canada 20
KR - Corea 19
MX - Messico 19
JP - Giappone 18
BE - Belgio 13
AR - Argentina 12
RU - Federazione Russa 11
IL - Israele 10
PK - Pakistan 10
IQ - Iraq 9
NL - Olanda 9
VE - Venezuela 9
ES - Italia 8
PL - Polonia 8
TR - Turchia 8
ZA - Sudafrica 8
ID - Indonesia 7
CZ - Repubblica Ceca 6
MA - Marocco 5
SA - Arabia Saudita 5
CO - Colombia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CH - Svizzera 3
CL - Cile 3
EC - Ecuador 3
EG - Egitto 3
ET - Etiopia 3
EU - Europa 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
NI - Nicaragua 3
PE - Perù 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
AU - Australia 2
BB - Barbados 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
IE - Irlanda 2
KH - Cambogia 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
RO - Romania 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KY - Cayman, isole 1
LB - Libano 1
MN - Mongolia 1
MU - Mauritius 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 63.943
Salva come PNG Salva come JPEG
Città #
Cagliari 57.701
Uta 902
Ashburn 284
Singapore 272
Fairfield 250
Chandler 238
Woodbridge 237
San Jose 156
Ann Arbor 150
Dallas 114
Wilmington 113
Seattle 112
Houston 97
Nyköping 96
Beijing 93
Cambridge 91
Boardman 83
Jacksonville 83
Dearborn 71
New York 69
Los Angeles 59
Shanghai 54
Hong Kong 44
The Dalles 42
Santa Clara 41
Council Bluffs 39
Nanjing 39
Ho Chi Minh City 33
Helsinki 32
Boston 28
Lauterbourg 25
Munich 23
Dong Ket 22
Hanoi 21
Seoul 19
Milan 18
São Paulo 18
Hefei 17
Frankfurt am Main 15
Rome 15
Guangzhou 14
San Diego 14
Brussels 13
Tokyo 13
Buffalo 11
Toronto 11
Chicago 10
Haiphong 10
Nanchang 10
Redondo Beach 10
Sassari 10
Shenyang 10
Falls Church 9
Hebei 9
London 9
Mexico City 9
Brooklyn 8
Jinan 7
Phoenix 7
Redwood City 7
Turku 7
Beersheba 6
Da Nang 6
Jiaxing 6
Kunming 6
Mountain View 6
New Delhi 6
Norwalk 6
Oristano 6
Padova 6
Alexandria 5
Atlanta 5
Columbus 5
Florence 5
Johannesburg 5
Poplar 5
Pune 5
Rio de Janeiro 5
Tianjin 5
Warsaw 5
Caracas 4
Cardiff 4
Grottammare 4
Istanbul 4
Miami 4
Montreal 4
Sestu 4
Shenzhen 4
Stockholm 4
Washington 4
Zhengzhou 4
Addis Ababa 3
Asunción 3
Baghdad 3
Bangkok 3
Belo Horizonte 3
Brasília 3
Bắc Ninh 3
Bến Tre 3
Changsha 3
Totale 62.199
Salva come PNG Salva come JPEG
Nome #
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.659
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.552
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway 3.029
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2.947
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 2.789
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia 2.785
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2.692
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease 2.639
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 2.534
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease 2.525
Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age 2.474
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging 2.395
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2.354
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A2A receptor antagonists 2.323
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.113
Farmaci antiparkinsoniani ed attivi in altri disturbi motori 1.834
Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration 1.808
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.798
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.784
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat 1.659
Antiparkinsonian actions and interactions of adenosine antagonists 1.652
null 1.651
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats 1.217
Adenosine A2A receptor antagonist treatment of Parkinson’s disease 1.145
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions 1.141
null 1.012
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 968
null 967
null 801
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease 759
Fos expression induced by olanzapine and risperidone in the central extended amygdala 705
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 700
null 410
Farmaci antiparkinsoniani ed attivi in altri disturbi motori 405
Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats 284
Extract from Nasco pomace loaded in nutriosomes exerts anti-inflammatory effects in the MPTP mouse model of Parkinson's disease 193
Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease 173
A2A Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson’s Disease 152
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease 105
Totale 64.133
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.739 0 232 151 142 220 225 284 189 218 351 323 404
2022/20234.735 455 676 566 405 420 425 236 285 314 333 414 206
2023/20244.061 199 201 148 258 399 665 659 300 172 282 339 439
2024/20255.398 730 945 849 883 440 560 531 67 167 72 81 73
2025/20262.725 227 108 233 161 244 187 682 172 162 279 161 109
2026/202757 44 13 0 0 0 0 0 0 0 0 0 0
Totale 64.133